Wednesday, November 25, 2020
Philly News For Your Information


AstraZeneca, Oxford University buoyed by vaccine response

By PhillyNews.FYI , in News , at October 26, 2020 Tags: , , , ,


British pharma giant AstraZeneca said on Monday trials of its coronavirus vaccine pioneered with Oxford University had shown “encouraging” responses among elderly, as well as younger participants.

The potential vaccine, one of 10 around the world in the most advanced phase III of trials, showed “strong immune responses” in all adult groups during the previous stage, according to an update from Oxford.

ADVERTISEMENT

An AstraZeneca spokesman said the initial results “further build the body of evidence for the safety and immunogenicity” of its experimental vaccine.

“It is encouraging to see immunogenicity responses were similar between older and younger adults, the spokesman added.

The positive news emerged in data on the safety and immune responses of participants in the phase II stage of the trial Oxford has submitted for peer review in a medical journal.

They include results for UK volunteers aged 56-69 and over 70, with formal publication of the data expected “in the coming weeks”.

“Our ongoing trials will provide further data, but this marks a key milestone and reassures us that the vaccine is safe for use and induces strong immune responses in both parts of the immune system in all adult groups,” the university said.

ADVERTISEMENT

Oxford and AstraZeneca have been trialing their potential vaccine for months in various countries around the world.

It was suspended worldwide on September 6 after a participant’s illness, but resumed shortly thereafter in Britain, and in the following weeks in South Africa, Brazil and Japan.

Authorities determined the illness was not apparently linked to the vaccine, with the US Food and Drug Administration also authorising the restart in the United States at the weekend.

ADVERTISEMENT

The AstraZeneca/Oxford vaccine is one of the most promising and advanced in the world to combat the global pandemic, which has now claimed the lives of 1.1 million people.

Many countries are counting on using it to inoculate their populations.

ADVERTISEMENT

The drugmaker pre-sold hundreds of millions of doses on several continents, and signed partnership deals with other producers to ensure the doses could be made locally.

UK Health Secretary Matt Hancock further fuelled optimism Monday, noting in an interview that once approved the “bulk” of the vaccine’s rollout could occur in Britain before next summer.

© 2020 AFP

Enjoy good journalism?

… then let us make a small request. The COVID crisis has slashed advertising rates, and we need your help. Like you, we here at Raw Story believe in the power of progressive journalism. Raw Story readers power David Cay Johnston’s DCReport, which we’ve expanded to keep watch in Washington. We’ve exposed billionaire tax evasion and uncovered White House efforts to poison our water. We’ve revealed financial scams that prey on veterans, and legal efforts to harm workers exploited by abusive bosses. And unlike other news outlets, we’ve decided to make our original content free. But we need your support to do what we do.

Raw Story is independent. Unhinged from corporate overlords, we fight to ensure no one is forgotten.

We need your support in this difficult time. Every reader contribution, whatever the amount, makes a tremendous difference. Invest with us. Make a one-time contribution to Raw Story Investigates, or click here to become a subscriber. Thank you. Click to donate by check.

Value Raw Story?

… then let us make a small request. The COVID crisis has cut advertising rates in half, and we need your help. Like you, we believe in the power of progressive journalism — and we’re investing in investigative reporting as other publications give it the ax. Raw Story readers power David Cay Johnston’s DCReport, which we’ve expanded to keep watch in Washington. We’ve exposed billionaire tax evasion and uncovered White House efforts to poison our water. We’ve revealed financial scams that prey on veterans, and efforts to harm workers exploited by abusive bosses. We need your support to do what we do.

Raw Story is independent. You won’t find mainstream media bias here. Every reader contribution, whatever the amount, makes a tremendous difference. Invest with us in the future. Make a one-time contribution to Raw Story Investigates, or click here to become a subscriber. Thank you.

Report typos and corrections to: [email protected].

Comments


Leave a Reply